BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 5
• 8
• 9
• 10
• 11
• 12
• 15
• 16
• 17
• 18
• 19
• 22
• 23
• 24
• 25
• 26
• 29
• 30
• 31

• Policy

  Mylan Laboratories Inc. Settles Its First-to-File Opportunity on Levetiracetam with UCB Pharma

  October 5, 2007

   · 

  2 min read
• Biotech Bay

  Cerimon Pharmaceuticals, Inc. to Present at the 2007 Biotechnology Industry Organization (BIO) Investor Forum

  October 5, 2007

   · 

  1 min read
• Pharm Country

  VioQuest Pharmaceuticals, Inc. to Present at Biotechnology Industry Organization (BIO) InvestorForum in San Francisco

  October 5, 2007

   · 

  3 min read
• Policy

  Pozen, Inc. Plans to Submit Response to Approvable Letter For Trexima(TM) Within the Next Ten Days

  October 5, 2007

   · 

  1 min read
• Business

  Bioject Medical Technologies Inc. Files Form 8-K Describing Employment Agreement with New Chief Executive Officer

  October 5, 2007

   · 

  1 min read
• Drug Development

  Surface Logix Presents Positive Phase 1 Repeat-Dose Trial Data on SLx-4090

  October 5, 2007

   · 

  4 min read
• Policy

  Caraco Pharmaceutical Laboratories, Ltd. Announces Tentative FDA Approval for Generic Zyrtec Chewable(R)

  October 5, 2007

   · 

  2 min read
• Deals

  Avesthagen-CIPLA JV Acquires State of the Art Biological Company Siegfried Biologics GmbH in Germany

  October 5, 2007

   · 

  1 min read
• Drug Development

  Argenes Initiates Phase I Clinical Study of ARG098 (anti-Fas IgM monoclonal antibody), a Novel Therapeutics for Rheumatoid Arthritis, in Europe

  October 5, 2007

   · 

  1 min read
• Deals

  MAP Pharmaceuticals, Inc. Announces Pricing of Its Initial Public Offering

  October 5, 2007

   · 

  2 min read